Effective Date Clause Example with Variations from Business Contracts

Effective Date. This Plan shall become effective upon the date immediately preceding the date upon which the registration statement on Form S-1 that is filed by the Company with respect to its initial public offering is declared effective by the Securities and Exchange Commission following stockholder approval in accordance with applicable state law, the Company's bylaws and articles of incorporation, each as amended, and applicable stock exchange rules. 10 APPENDIX A Designated Subsidiaries None 11 EX-10.3 8... tv527886_ex10-3.htm EXHIBIT 10.3 EX-10.11 13 d945651dex1011.htm EX-10.11 EX-10.11 Exhibit 10.3 SPRINGWORKS THERAPEUTICS, 10.11 PRAXIS PRECISION MEDICINES, INC. 2019 2020 EMPLOYEE STOCK PURCHASE PLAN The purpose of the SpringWorks Therapeutics, Praxis Precision Medicines, Inc. 2019 2020 Employee Stock Purchase Plan ("the Plan") (the "Plan") is to provide eligible employees of SpringWorks Therapeutics, Praxis Precision Medicines, Inc. (the "Company") and each Designated Subsidiary (as defined in Section 11) with opportunities to purchase shares of the Company's common stock, par value $0.0001 per share (the "Common Stock"). An aggregate of 442,153 327,102 shares of Common Stock in the aggregate have been approved and reserved for this purpose, plus on January 1, 2020, 2021, and each January 1 thereafter through January 1, 2029, 2030, the number of shares of Common Stock reserved and available for issuance under the Plan shall be cumulatively increased by the least of (i) one percent (1%) percent of the number of shares of Common Stock issued and outstanding on the immediately preceding December 31st, (ii) 663,229 327,102 shares of Common Stock or (iii) such number of shares of Common Stock as determined by the Administrator. The Plan is intended to constitute an "employee stock purchase plan" within the meaning of Section 423(b) of the Internal Revenue Code of 1986, as amended (the "Code"), and shall be interpreted in accordance with that intent. View More

Effective Date. This Plan shall become effective upon the date immediately preceding the date upon which the registration statement on Form S-1 that is filed by the Company with respect to its initial public offering is declared effective by the Securities and Exchange Commission Closing Date following stockholder approval in accordance with applicable state law, the Company's bylaws and articles of incorporation, each as amended, and applicable stock exchange rules. 10 APPENDIX A Designated Subsidiaries None None. 11 EX-10.3 8 tv527886_ex10-3.htm EXHIBIT 10.3 EX-10.6 5 d203347dex106.htm EX-10.6 EX-10.6 Exhibit 10.3 SPRINGWORKS 10.6 TANGO THERAPEUTICS, INC. 2019 2021 EMPLOYEE STOCK PURCHASE PLAN The purpose of the SpringWorks Tango Therapeutics, Inc. 2019 2021 Employee Stock Purchase Plan ("the Plan") (the "Plan") is to provide eligible employees of SpringWorks Tango Therapeutics, Inc. (the "Company") and each Designated Subsidiary (as defined in Section 11) with opportunities to purchase shares of the Company's common stock, par value $0.0001 $0.001 per share (the "Common Stock"). An aggregate of 442,153 949,873 shares of Common Stock in the aggregate have been approved and reserved for this purpose, plus on January 1, 2020, 2022, and each January 1 thereafter through January 1, 2029, 2031, the number of shares of Common Stock reserved and available for issuance under the Plan shall be cumulatively increased by the least of (i) one percent (1%) percent of the number of shares of Common Stock issued and outstanding on the immediately preceding December 31st, (ii) 663,229 949,873 shares of Common Stock or (iii) such number of shares of Common Stock as determined by the Administrator. The Plan is intended to constitute an "employee stock purchase plan" within the meaning of Section 423(b) of the Internal Revenue Code of 1986, as amended (the "Code"), and shall be interpreted in accordance with that intent. View More

Effective Date. This Plan shall become effective upon the date immediately preceding the date upon which the registration statement on Form S-1 that is filed by the Company with respect to its initial public offering is declared effective by the Securities and Exchange Commission following stockholder approval in accordance with applicable state law, the Company's bylaws and articles of incorporation, each as amended, and applicable stock exchange rules. DATE APPROVED BY BOARD OF DIRECTORS: AUGUST 11, 2020... DATE APPROVED BY STOCKHOLDERS: AUGUST 14, 2020 10 APPENDIX A Designated Subsidiaries None None. 11 EX-10.3 8 tv527886_ex10-3.htm EXHIBIT 10.3 EX-10.5 9 d940105dex105.htm EX-10.5 EX-10.5 Exhibit 10.3 SPRINGWORKS 10.5 KYMERA THERAPEUTICS, INC. 2019 2020 EMPLOYEE STOCK PURCHASE PLAN The purpose of the SpringWorks Kymera Therapeutics, Inc. 2019 2020 Employee Stock Purchase Plan ("the Plan") (the "Plan") is to provide eligible employees of SpringWorks Kymera Therapeutics, Inc. (the "Company") and each Designated Subsidiary (as defined in Section 11) with opportunities to purchase shares of the Company's common stock, par value $0.0001 per share (the "Common Stock"). An aggregate of 442,153 445,653 shares of Common Stock in the aggregate have been approved and reserved for this purpose, plus on January 1, 2020, 2021, and each January 1 thereafter through January 1, 2029, 2030, the number of shares of Common Stock reserved and available for issuance under the Plan shall be cumulatively increased by the least of (i) one percent (1%) percent of the number of shares of Common Stock issued and outstanding on the immediately preceding December 31st, (ii) 663,229 438,898 shares of Common Stock Stock, or (iii) such number of shares of Common Stock as determined by the Administrator. The Plan is intended to constitute an "employee stock purchase plan" within the meaning of Section 423(b) of the Internal Revenue Code of 1986, as amended (the "Code"), and shall be interpreted in accordance with that intent. View More

Effective Date. This Plan shall become effective upon the date immediately preceding the date upon which the registration statement on Form S-1 that is filed by the Company with respect to its initial public offering is declared effective by the Securities and Exchange Commission following stockholder approval in accordance with applicable state law, the Company's bylaws and articles of incorporation, each as amended, and applicable stock exchange rules. 10 APPENDIX A Designated Subsidiaries None None. 11... EX-10.3 8 tv527886_ex10-3.htm 13 a2238646zex-10_3.htm EX-10.3 EXHIBIT 10.3 Exhibit 10.3 SPRINGWORKS THERAPEUTICS, AXCELLA HEALTH INC. 2019 EMPLOYEE STOCK PURCHASE PLAN The purpose of the SpringWorks Therapeutics, Axcella Health Inc. 2019 Employee Stock Purchase Plan ("the Plan") is to provide eligible employees of SpringWorks Therapeutics, Axcella Health Inc. (the "Company") and each Designated Subsidiary (as defined in Section 11) with opportunities to purchase shares of the Company's common stock, par value $0.0001 $0.001 per share (the "Common Stock"). An aggregate of 442,153 237,181 shares of Common Stock in the aggregate have been approved and reserved for this purpose, plus on January 1, 2020, and each January 1 thereafter through January 1, 2029, the number of shares of Common Stock reserved and available for issuance under the Plan shall be cumulatively increased by the least of (i) one percent (1%) percent of the number of shares of Common Stock issued and outstanding on the immediately preceding December 31st, (ii) 663,229 237,181 shares of Common Stock or (iii) such number of shares of Common Stock as determined by the Administrator. The Plan is intended to constitute an "employee stock purchase plan" within the meaning of Section 423(b) of the Internal Revenue Code of 1986, as amended (the "Code"), and shall be interpreted in accordance with that intent. View More

Effective Date. This Plan shall become effective upon the date immediately preceding the date upon which the registration statement on Form S-1 that is filed by the Company with respect to its initial public offering is declared effective by the Securities and Exchange Commission following stockholder approval in accordance with applicable state law, the Company's bylaws and articles of incorporation, each as amended, and applicable stock exchange rules. 10 APPENDIX A Designated Subsidiaries None None. 11... EX-10.3 8 tv527886_ex10-3.htm EXHIBIT 10.3 5 a2236172zex-10_3.htm EX-10.3 Exhibit 10.3 SPRINGWORKS RUBIUS THERAPEUTICS, INC. 2019 2018 EMPLOYEE STOCK PURCHASE PLAN The purpose of the SpringWorks Rubius Therapeutics, Inc. 2019 2018 Employee Stock Purchase Plan ("the Plan") is to provide eligible employees of SpringWorks Rubius Therapeutics, Inc. (the "Company") and each Designated Subsidiary (as defined in Section 11) with opportunities to purchase shares of the Company's common stock, par value $0.0001 $0.001 per share (the "Common Stock"). An aggregate of 442,153 951,488 shares of Common Stock in the aggregate have been approved and reserved for this purpose, plus on January 1, 2020, 2019, and each January 1 thereafter through January 1, 2029, 2028, the number of shares of Common Stock reserved and available for issuance under the Plan shall be cumulatively increased by the least of (i) one percent (1%) percent of the number of shares of Common Stock issued and outstanding on the immediately preceding December 31st, (ii) 663,229 951,488 shares of Common Stock or (iii) such number of shares of Common Stock as determined by the Administrator. The Plan is intended to constitute an "employee stock purchase plan" within the meaning of Section 423(b) of the Internal Revenue Code of 1986, as amended (the "Code"), and shall be interpreted in accordance with that intent. View More